Your browser doesn't support javascript.
loading
Study on the mechanism underlying Trichosanthis peel injection-induced improvements in myocardial fibrosis markers in patients with chronic heart failure.
He, Yue; Gu, Xinsheng; Yang, Zhou; Wang, Hao; Liu, Ping.
Afiliação
  • He Y; Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Gu X; Department of Cardiology, Shanghai Eighth People's Hospital, Shanghai, China.
  • Yang Z; Department of Cardiology, Shanghai Eighth People's Hospital, Shanghai, China.
  • Wang H; Department of General Surgery, Affiliated Cancer Hospital of Fudan University, Shanghai, China.
  • Liu P; Experimental Teaching Center of Basic Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Clin Exp Pharmacol Physiol ; 51(4): e13848, 2024 04.
Article em En | MEDLINE | ID: mdl-38423007
ABSTRACT
In this research, we aimed to observe the changes in myocardial fibrosis indices in patients with chronic heart failure before and after treatment and to evaluate the anti-chronic heart failure and ventricular remodelling effects of Trichosanthis peel (TP) injection. This study was a single-center, open, single-blind, randomized controlled study with an optimal efficacy design. Patients were consecutively and randomly divided into two groups, with 36 patients in the TP injection group and 36 patients in the conventional treatment group. ELISA was used to measure changes in myocardial fibrosis indices before and after discharge, including transforming growth factor ß (TGF-ß), serum hyaluronic acid (HA), type I procollagen (PCI), laminin (LN) and type III procollagen (PCIII). There was no significant difference between the two groups in clinical data or baseline level of myocardial fibrosis before treatment. After treatment, compared with the conventional treatment group, the myocardial fibrosis index was significantly decreased following TP injection. Our findings indicate that TP injection combined with conventional medicine can attenuate myocardial fibrosis by reducing angiotensin II, aldosterone, TGFß, HA, PCI, metallomatrix proteinase 2, connective tissue growth factor and LN and promote ventricular remodelling in patients with chronic heart failure.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Líquidos Corporais / Insuficiência Cardíaca Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Líquidos Corporais / Insuficiência Cardíaca Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article